Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
A phase 3 trial of Aspirin, Dexamethasone and Diethylstilbestrol in Prostate cancer, run by St. Bartholomew's Hospital, completed.
Overview
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer is a phase 3 interventional study registered as NCT00316927 by St. Bartholomew's Hospital, with 260 participants recorded, started 2002-12. Interventions recorded: acetylsalicylic acid, dexamethasone, diethylstilbestrol. Conditions recorded: Prostate Cancer.
Linked to the drug Diethylstilbestrol because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialHormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Shares Aspirin, Prostate cancer and the tag pipeline.
- TrialChemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
Shares Dexamethasone, Prostate cancer and the tag pipeline.
- TrialSafety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Shares Prostate cancer and the tag pipeline.
- TrialPhase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
Shares Prostate cancer and the tag pipeline.
- TrialPhase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
Shares Prostate cancer and the tag pipeline.
- TrialEvaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Shares Prostate cancer and the tag pipeline.
- TrialSubstudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
Shares Dexamethasone, Prostate cancer and the tag pipeline.
- TrialSafety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
Shares Dexamethasone and the tag pipeline.